These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32323826)

  • 1. Antitumor effect of lenalidomide in malignant glioma cell lines.
    Hanashima Y; Sano E; Sumi K; Ozawa Y; Yagi C; Tatsuoka J; Yoshimura S; Yamamuro S; Ueda T; Nakayama T; Hara H; Yoshino A
    Oncol Rep; 2020 May; 43(5):1580-1590. PubMed ID: 32323826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of veratramine via the phosphatidylinositol-3-kinase/serine-threonine kinase/mechanistic target of rapamycin and its downstream signaling pathways in human glioblastoma cell lines.
    Kim D; Kwon W; Park S; Kim W; Park JK; Han JE; Cho GJ; Yun S; Han SH; Kim MO; Ryoo ZY; Choi SK
    Life Sci; 2022 Jan; 288():120170. PubMed ID: 34826438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.
    Ochiai Y; Sano E; Okamoto Y; Yoshimura S; Makita K; Yamamuro S; Ohta T; Ogino A; Tadakuma H; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
    Oncol Rep; 2018 Feb; 39(2):537-544. PubMed ID: 29251333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
    Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
    Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
    Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
    Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.
    Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X
    Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.
    Gorjala P; Cairncross JG; Gary RK
    Cell Prolif; 2016 Dec; 49(6):698-709. PubMed ID: 27611480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
    Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
    Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
    Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
    Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.
    Kolodziej M; Goetz C; Di Fazio P; Montalbano R; Ocker M; Strik H; Quint K
    Oncol Rep; 2015 Sep; 34(3):1549-56. PubMed ID: 26151768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.
    Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M
    J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
    Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
    Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
    J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
    Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
    Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
    Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
    Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action.
    Punganuru SR; Artula V; Zhao W; Rajaei M; Deokar H; Zhang R; Buolamwini JK; Srivenugopal KS; Wang W
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
    Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
    Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells.
    Khan M; Rasul A; Yi F; Zhong L; Ma T
    Asian Pac J Cancer Prev; 2011; 12(12):3235-8. PubMed ID: 22471459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.